INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTA..

ISTH 2024 Congress

 

June, 22-26 Bangkok
Close
N. Poster
Poster title
Applicant name
Status
  PB-0013 Protein carbonylation in patients with COPD and effects of statin treatment: a randomized controlled trial Anna Hojda Received Received
  PB-21 Training future leaders in antithrombotic management: the Certificate of Advanced Studies in Antithrombotic Management (CAS-AM) Hugo ten Cate Received Received
  PB-0027 Time to Bleeding After DOAC initiation for Venous Thromboembolism or Atrial Fibrillation Jordan Schaefer Received Received
  PB-0028 Multi-center Adoption and Impact of a DOAC Dashboard to Reduce Off-Label DOAC Prescribing Geoffrey Barnes Received Received
  PB-0030 Relationship between stroke history and the occurrence of adverse events after mitral valve replacement in patients with atrial fibrillation combined with heart valve disease xinsheng Yan Received Received
  PB-0036 Increased complement activation markers in antiphospholipid syndrome-related ischemic stroke correlate with platelet hyperreactivity Ibrahim Tohidi-Esfahani Received Received
  PB-0046 Percent Reduction From Baseline Is a Better Target Than Follow-Up Levels in Low-Density Lipoprotein Cholesterol Lowering Therapy For Patients With Acute Myocardial Infarction Kyung Hoon Cho Received Received
  PB-0049 Fibroblast Growth Factor 23 is Associated With High-sensitivity Cardiac Troponin I, T and Left Ventricular Hypertrophy in Patients With Chronic Kidney Disease satoshi fujii Received Received
  PB-0050 FGF23 Mediates Cardio-Renal Interaction in Asymptomatic Subjects With Chronic Elevation of Serum High-sensitivity Troponin: Implications for Multisystem Cardio-renal Risk Satoshi Fujii Received Received
  PB-0051 Rapid eGFRcys Decline Closely Correlates With Episodes of Acute Coronary Syndrome in Asian Patients with Type 2 Diabetes Satoshi Fujii Received Received
  PB-0058 Socio-demographic and lifestyle factors associated with cardiovascular disease in a large prospective cohort of healthy subjects Anna Falanga Received Received
  PB-0062 Rural-Urban Based Differences in Patients with Thromboangiitis Obliterans (Buergers Disease): Insights from Nationwide Inpatient Sample Wenzhu Li Received Received
  PB-0064 Relationship of decreased levels of omentin-1 with insulin resistance and prothrombotic state in peripheral vascular disease Oleksii Korzh Received Received
  PB-0069 The assessment of the role of ROTEM in thrombosis risk evaluation of the severe form of COVID 19 patients Viola Popov Received Received
  PB-0070 Fluorescence cross-correlation spectroscopy based measurement of von Willebrand factor multimer size for classifying patients with acquired von Willebrand syndrome Lausonia Ramaswamy Received Received
  PB-0073 FIX Post infusion monitoring surveys: Results and analysis from the updated UK NEQAS BC Haemophilia programmes 2024 CHRISTOPHER REILLY-STITT Received Received
  PB-0074 Experience of interpretating F8 missense variants using F8-specific variant interpretation guidelines published by the ClinGen Coagulation Factor Deficiency Expert Panel Yohann JOURDY Received Received
  PB-0077 Urinary thromboxane to assess thromboinflammation: a future biomarker for precision medicine JEFFREY DAHLEN Received Received
  PB-0079 Experience of Lupus anticoagulant laboratory diagnosis by applying the 2020 ISTH-SSC guidelines from a single tertiary care center in Kerala Reema Abraham Received Received
  PB-0081 Evaluation of a new Stago system sthemO dRVV screen and confirm on sthemO 301 coagulation analyzer for lupus anticoagulant detection Sylvain LAMOINE Received Received
  PB-0083 Investigating genotype-phenotype relationships in thrombosis patients with PROC, PROS1 or SERPINC1 variants Christine Van Laer Received Received
  PB-0084 Super formula for soluble C-type lectin-like receptor 2 x D-dimer in patients with acute cerebral infarction Hideo Wada Received Received
  PB-0085 The evaluation of hemostatic abnormalities in congenital or acquired coagulation factor deficiency using a clot waveform. Hideo Wada Received Received
  PB-0086 Factor V and VII assay discrepancies in the UK NEQAS Blood Coagulation (BC) programme comparison with International Society on Thrombosis and Haemostasis (ISTH) SSC plasma standard results Ian Jennings Received Received
  PB-0087 Evaluation of the new Stago system, sthemO II, sthemO V and sthemO X on sthemO 301 analyzer for factors II, V and X deficiencies determination Sylvain LAMOINE Received Received
  PB-0089 Unfractionated Heparin measurement with Anti-Xa assays from the UK National External Quality assessment Blood Coagulation 2023. CHRISTOPHER REILLY-STITT Received Received
  PB-0091 Fast screening of direct oral factor Xa inhibitors, interferences in anti-Xa assays An Stroobants Received Received
  PB-0092 D-dimer kinetic variations on sthemO 301 to predict bleeding complications in ECMO patients Matthieu Bourdin Received Received
  PB-0094 A Novel, Point-of-care (POC) Portable Meter & Disposable Card, Viscoelastic Coagulation Diagnostic Platform for Hemostasis Management with complete results including fibrinolysis in under 10 minutes Abhishek Ramkumar Received Received
  PB-0098 Homogeneous Enzyme Immunoassay for the Direct Determination of Apixaban in Human Plasma Raj Singh Received Received
  PB-0099 Homogeneous Enzyme Immunoassay for the Direct Determination of Rivaroxaban in Human Plasma Raj Singh Received Received
  PB-0101 Evaluation of the new Stago system sthemO Anti-Xa M on sthemO 301 analyzer for monitoring heparin therapy. Joffrey Feriel Received Received
  PB-0103 A retrospective study of causes of prolonged PT in outpatient setting from a single tertiary care centre in southern India Reema Abraham Received Received
  PB-0104 International Normalised Ratio measurement data from the UK National External Quality Assessment for Blood Coagulation programme 2023. CHRISTOPHER REILLY-STITT Received Received
  PB-0106 Stability of cardiac biomarkers during long-term biospecimen banking JEFFREY DAHLEN Received Received
  PB-0108 External quality control for hemophilia laboratories: five year experience of the Italian Hemophilia Centers Angelo Claudio Molinari Received Received
  PB-0115 Pre analytical variables: A take on haemolysis and ways of dealing with it as reported by the United Kingdom National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC). IAN JENNINGS Received Received
  PB-0116 Pre analytical variables: Haemolysis Supplementary Exercise, a report from United Kingdom National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) IAN JENNINGS Received Received
  PB-0117 Nordic Biomarker MRX PT DOAC assay on Sysmex CN6000 Analysers Jackie Dobson-Storr Received Received
  PB-0119 Lab Modified Test in Detection of Antithrombin Deficiency in era of IVDR/FDA Requirements Kieron HICKEY Received Received
  PB-122 Automated algorithm for interpretation of functional Lupus anticoagulant testing Chiara Adele Elena Novelli Received Received
  PB-0124 Establishment of reference intervals for platelet aggregation tests on new automated coagulation analyzer Desiree Coen Herak Received Received
  PB-0125 Clinical performance evaluation of a new Stago system for Factor IX level determination: sthemO IX on sthemO 301 Joffrey Feriel Received Received
  PB-0126 Clinical performance evaluation of a new Stago system for Factor VII levels determination: sthemO VII on sthemO 301 with sthemO PT Joffrey Feriel Received Received
  PB-0129 Overcoming High Optical Densities in a Chromogenic assay Sunny Jamati Received Received
  PB-0132 Determination and verification of reference intervals on the new Stago coagulation analyzer sthemO 301 Joke Konings Received Received
  PB-0139 Clinical performance evaluation of a new Stago system for Factor VIII level determination: sthemO VIII on sthemO 301 Joffrey Feriel Received Received
  PB-0149 Detection of thrombotic state using a clot waveform analysis Hideo Wada Received Received
  PB-0157 Viscoelastic tests as screening in congenital hemorrhagic disease, cases report. Instituto Nacional de Pediatria, Mexico City, Mexico MARA NUNEZ TOSCANO Received Received
  PB-0159 Assessment of the impact of underfilled samples on Coagulation laboratory tests using Sysmex CN6000 analysers. Lee Beckett Received Received
  PB-0164 Identifying the differences in the structural etiology underlying coagulation Factor XIII mutations based on a 2.4 cryo-EM structure of the coagulation Factor XIII-A2B2 complex. Sneha Singh Received Received
  PB-0169 Direct relation between hypercoagulability and high fibrinogen levels measured by thrombelastography in patients with high-risk coronary artery disease and COVID-19 Jeffrey Dahlen Received Received
  PB-0170 Preoperative biomarker panel with fibrinogen and FVIII improves prognostic evaluation of pancreas cancer with neoadjuvant therapy Riitta Lassila Received Received
  PB-0177 D-dimer Inversely Correlates with Neurocognitive Performance in Atrial Fibrillation: A 7-year Follow Up study Pratintip Lee Received Received
  PB-0200 Clinical outcomes from treatment with extended half-life and standard half-life products in a hemophilia patients cohort in Colombia SASKIA PRASCA Received Received
  PB-0209 Effectiveness and safety of efmoroctocog alfa (a recombinant factor VIII Fc) across body mass index (BMI) categories: pooled data from two non-interventional phase 4 studies (A-SURE/PREVENT) Daniela Bruni Received Received
  PB-0212 Evaluation of Omfiloctocog alfa (SCT800) Efficacy in Real-World Treatment of Severe Hemophilia A in China: Insights from the SURPASS Study Sen Yu Received Received
  PB-0214 Synovial immune and inflammatory gene regulation is influenced differently by recombinant FVIII or FVIII-Fc fusion protein after hemarthrosis in FVIII-deficient mice Bilgimol Chumappumkal Joseph Received Received
  PB-0219 The World Federation of Hemophilia Living Guidelines Model Donna Coffin Received Received
  PB-0221 Persistent and stable therapeutic levels of transgenic FVIII expression following AAV delivery to adult and infant hemophilic dogs Laura Swystun Received Received
  PB-0224 Inflammatory cytokine expression after hemarthrosis differs with recombinant FVIII and FVIII-Fc fusion replacement in Factor VIII-deficient mice Bilgimol Chumappumkal Joseph Received Received
  PB-0225 High Bleed Control with a Single 225 g/kg Eptacog Beta Dose in Adult and Adolescent Hemophilia A or B Persons with Inhibitors Thomas Wilkinson Received Received
  PB-0229 Results from the Taiwanese cohort in GENEr8-1: bleeding rates, factor VIII usage, quality of life and safety in severe Hemophilia A patients after gene therapy Teresa Raquel Moraes Ramos Received Received
  PB-0232 Measuring FVIII inhibitors in samples containing emicizumab: results of a multi-laboratory field study Geoffrey Kershaw Received Received
  PB-0236 Evaluation of real-world peri-operative outcomes in patients with haemophilia A (HA) with or without inhibitors on emicizumab prophylaxis in Australia Radha Ramanan Received Received
  PB-0238 Clinical and patient-centered outcomes among Italian people with severe haemophilia A receiving prophylaxis: real-world findings from Cost of Haemophilia: a Socio-economic Survey (CHESS) data base rita carlotta Santoro Received Received
  PB-0242 A phase I trial evaluating safety and pharmacokinetics in human and an ex vivo pharmacodynamics study in hemophilia patients of KN057, the first antiTFPI monoclonal antibody in China Feng Xue Received Received
  PB-0243 Detection of an anti-drug antibody against emicizumab in clinical practice: experience from one center in France Claire Auditeau Received Received
  PB-0249 Development of the first small molecule therapy for the treatment of hemophilia A and B Ashay Gore Received Received
  PB-0251 Indirect comparison of prophylaxis efficacy between simoctocog alfa and efanesoctocog alfa in severe hemophilia A and their cost in the United States Greg Melroe Received Received
  PB-0254 The Experience of Using Damoctocog Alfa Pegol During Surgery in Patients Treated at the Bonn Center Darwin Health Communications Darwin Health Communications Received Received
  PB-0255 Comparison of FVIII and concizumab in thrombin generation assays under different conditions Jacob Lund Received Received
  PB-260 Evaluating Effectiveness and Safety in the Fourth Interim Analysis of the HEM-POWR Study: A Post Hoc Analysis of Patients From Nordic Study Sites Jennifer Humbert Received Received
  PB-261 Investigating effectiveness and safety of extended dosing regimens of damoctocog alfa pegol in the real-world HEM-POWR study Doreen Kruk Received Received
  PB-0262 Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Third interim analysis of the non-interventional study EMIIL Katrin Blumbach Received Received
  PB-0267 Long-read nanopore sequencing used for comprehensive structural variant characterization in severe hemophilia patients. Nina Borràs Agustí Received Received
  PB-0271 Health Literacy of People with Haemophilia in China Results of a Cross-sectional, Community-Based Survey Karina Hsu Received Received
  PB-0279 Psychometrics of patient-reported outcomes measurement information system in von Willebrand disease, inherited platelet function disorders, and rare bleeding disorders Shannon van Hoorn Received Received
  PB-0290 Status of von Willebrand disease in a cohort of Colombian patients 2022-2023 Gina Alejandra Diaz Mosquera Received Received
  PB-0298 Functional multiplex activity assay reveals molecular perturbations in ADAMTS13 structure and composition Frida Miranda Received Received
  PB-0299 The dual neuroprotective and anti-inflammatory effects of acute constitutively active ADAMTS13 administration in preclinical models of intracerebral haemorrhage Chiara Ramponi Received Received
  PB-0302 ADAMTS13 can be a novel therapeutic option for acetaminophen-induced acute liver injury in mice Akihiro Sawa Received Received
  PB-0303 The role of VWF-ADAMTS13 axis in the pathogenesis of lung inflammation in mice Kohei Tatsumi Received Received
  PB-0307 ADAMTS13 activity method Comparison Thomas Pitchford Received Received
  PB-0309 ADAMTS13 activity as a novel biomarker in sepsis Joshua Muia Received Received
  PB-0313 A cohort study of 22 patients with immune-mediated thrombotic thrombocytopenic purpura in Taiwan Hsuan-Yu Lin Received Received
  PB-0317 Unravelling the disulfide-bonded states of antithrombin: Implications for anticoagulant activity Kenny Ningxin Lu Received Received
  PB-0319 Reduced plasma selenoprotein P is associated with type I antithrombin deficiency and prothrombotic clot phenotype Anna Hojda Received Received
  PB-0326 The synergistic effects of hypoxia and estrogen on Protein S gene expression Mohammad A Mohammad Received Received
  PB-0343 Localized recombinant human von Willebrand Factor influences in vivo angiogenesis in VWF-deficient mice Edwin Ocran Received Received
  PB-0345 The novel variable heavy chain antibody Syn-VWFA1 inhibits platelet von Willebrand factor interaction in solution Joke Konings Received Received
  PB-0348 High shear rate thrombi occlude blood flow by a cable of VWF and platelets Edouard Machenaud Received Received
  PB-0350 Deficiency of ultra-large von Willebrand factor multimers at diagnosis is associated with poor prognosis in acute immune-mediated thrombotic thrombocytopenic purpura. Noritaka Yada Received Received
  PB-0356 Acquired von Willebrand syndrome secondary to monoclonal gammopathy: a single centre case series. Quentin Van Thillo Received Received
  PB-0361 Acquired von willebrand disease in the diagnosis of IgM multiple myeloma Cecilia Guillermo Received Received
  PB-0371 The utility of D-dimer in excluding the diagnosis of proximal deep vein thrombosis in the anticoagulated population Bobby Gouin Received Received
  PB-0372 Significance of omentin-1 and visfatin in platelet activation and blood coagulation in patients with venous thromboembolism Oleksii Korzh Received Received
  PB-0378 Incidence of venous thromboembolic disease in covid-19 patients during hospitalization and within 90 days after discharge Carina Pizzarossa Received Received
  PB-0381 Anticoagulant treatment for isolated distal deep vein thrombosis: A systematic review and meta-analysis Walter Ageno Received Received
  PB-0389 Estimating in hospital and post-discharge venous and arterial thrombotic events in patients with COVID-19 Rushad Patell Received Received
  PB-0392 Cost-effectiveness of Venous Thromboembolism Prophylaxis Protocol Implementation Compared to Routine Clinical Practice in a Tertiary Hospital in Thailand Nutsiri Kittitirapong Received Received
  PB-0396 Understanding venous thromboembolic research end-user perspectives: A qualitative exploration to shape a core outcome set for venous thromboembolism treatment studies (VTE-COS) Lisa Duffet Received Received
  PB-0397 Long-term anticoagulation management in patients with venous thromboembolism: evaluation of an outpatient clinic led by a nurse practitioner Tessa Elling Received Received
  PB-0404 Risk of venous thromboembolism is not increased with short-term PM2.5 air pollution even among at risk groups Scott Woller Received Received
  PB-0407 Designation and application of Multi-dimensional continuous management index system for high-risk VTE discharged patients Ying Yang Received Received
  PB-0410 Clinical Outcomes of Enoxaparin 30 mg for Venous Thromboembolic Prophylaxis in Low-Weight Surgical Patients: A Retrospective Cohort Study Amjaad Alfahed Received Received
  PB-0415 Peri-operative VTE prophylaxis: call on an action Ying Yang Received Received
  PB-0419 Artificial Intelligence and Venous Thromboembolism: Talking to the Experts Rushad Patell Received Received
  PB-0425 Smart technology facilitated patient-centered venous thromboembolism management:A focus group study of patient priorities Yutao Guo Received Received
  PB-0432 Smart technology facilitating patient-centered venous thromboembolism management : pilot assessment for the adherence Zheqi Zhang Received Received
  PB-0440 Progestin drugs are not associated with an increased risk of thrombotic events in patients with severe inherited thrombophilia. A single-center retrospective cohort study Nicola Perin Received Received
  PB-0454 Women who achieved pregnancy after ovarian stimulation show prothrombotic fibrin clot phenotype compared to non-pregnant women: associations with neurohormones Anna Hojda Received Received
  PB-0464 D-dimer ratio to re-establish trimester-specific reference ranges of D-Dimer in pregnant women: a pooled study. jia Du Received Received
  PB-0474 Should anticoagulation be administered in all pregnant women with hereditary antithrombin deficiency? Maria Teresa De Sancho Received Received
  PB-0475 Thrombotic Microangiopathy during Pregnancy: The Role of ADAMTS13 Activity Eleni Gavriilaki Received Received
  PB-0485 Risk of venous thromboembolism in pregnant women hospitalized with severe infections: prospective analysis of 352 charts. Venina Barros Received Received
  PB-492 Fourth interim analysis of the HEM-POWR Study: A post hoc analysis of real-world effectiveness and safety of damoctocog alfa pegol in previously treated patients with haemophilia A in Taiwan Doreen Kruk Received Received
  PB-0493 SINGLE CENTER CROSS-SECTIONAL STUDY ON HEALTH RELATED QUALITY OF LIFE IN PEOPLE WITH HEMOPHILIA Angelo Claudio Molinari Received Received
  PB-0495 Treatment of Thrombotic Cardiovascular Diseases in People with Haemophilia: A Japanese Consensus Study Azusa Nagao Received Received
  PB-0497 smart medication Gene a collaboration and documentation platform according to hub & spoke model for gene therapy of hemophilia A/B David Schmoldt Received Received
  PB-0503 Clinical outcomes of people with hemophilia B treated with N9-GP in real-world settings: the Adelphi Disease Specific Programme hemophilia study Shwetha Shivamurthy Prashanth Received Received
  PB-0505 Long-term joint health outcomes with a recombinant factor VIII Fc from the 48-month prospective, observational A-MORE study: Third interim analysis of up to 24 months Daniela Bruni Received Received
  PB-0514 Joint health in patients with hemophilia: data from real-life practice in Colombia Saskia Pasca Tapia Received Received
  PB-519 Does emicizumab prophylaxis lead to FVIII inhibitor reduction in hemophilia A patients with positive inhibitors? Marija Milos Received Received
  PB-0521 The change in Haemophilia A therapy in Germany - a retrospective data analysis of product classes from smart medication ScanDoc documentation platform used in pharmacies David Schmoldt Received Received
  PB-523 Interim results from a non-interventional, post authorisation safety study of nonacog beta pegol as routine prophylaxis in patients with haemophilia B Robert Klamroth Received Received
  PB-524 Burden of difficult venous access in patients with Hemophilia A - Results from DIVA real-world data research Emina Suljovic Hadzimesic Received Received
  PB-0535 How much is the coagulation ability of emicizumab in hemophilia A patients treated with it, when converted to factor VIII activity? Teruhisa Fujii Received Received
  PB-0539 Analysis of emicizumab plasma concentrations in single centre cohort of people with Haemophilia A on emicizumab prophylaxis Lucy Neave Received Received
  PB-0543 Experience of switching to EHL-CFVIII or non-replacement therapies in patients with severe or moderate hemophilia a without inhibitor from the galician community: retrospective analysis Michael Calviño Suárez Received Received
  PB-0547 A Canadian Roundtable Discussion of the Peri-operative Use of Nonacog beta pegol (N9-GP) for Persons with Moderate to Severe Hemophilia B Man-Chiu Poon Received Received
  PB-0553 Epidemiological survey and data analysis of hemophilia patients in Henan Province of China Bingjie Ding Received Received
  PB-0558 Efficacy, Safety and Quality of Life Three Years After Gene Transfer With Valoctocogene Roxaparvovec in a Brazilian Cohort Teresa Raquel Moraes Ramos Received Received
  PB-0565 Phenotypic characterisation of congenital fibrinogen disorders in Australia Radha Ramanan Received Received
  PB-0569 Autosomal Recessive Factor XI Deficiency Caused by a Common Ashkenazi Jewish Variant and a Novel, de novo Missense Variant miguel escobar Received Received
  PB-579 Safety of continuous long term antifibrinolytic therapy in patients with Hereditary Hemorrhagic Telangiectasia Sheh-Li Chen Received Received
  PB-0591 Differences in Types of Thromboses and Risk Factors in Males versus Females in Adolescent Thromboembolism in the Throm-PED Registry Lakshmi Srivaths Received Received
  PB-598 Primary role in assessing the risk of severe early onset preeclampsia of phospholipid-dependent procoagulant clotting time and initiation phase of thrombin generation test patrick Van Dreden Received Received
  PB-0600 Tissue factor, leukemia inhibitory factor , thrombomodulin, D-Dimer, thrombin generation and procoagulant phospholipid dependent clotting time are predictive for in vitro fertilization outcome patrick Van Dreden Received Received
  PB-0605 Real World Data on Safety and Efficacy of Emicizumab in Previously Untreated and Minimally Treated Patients under 18 months Eman Hassan Received Received
  PB-0606 Bone Health Screening for Pediatric Patients on Chronic Warfarin Therapy: A Quality Improvement Initiative Vilmarie Rodriguez Received Received
  PB-0615 Racial and age-specific differences in Rotational Thromboelastometry (ROTEM) and conventional coagulation laboratory tests in a healthy pediatric population Marium Malik Received Received
  PB-0641 The benefits of prophylaxis with low dose factor VIII in the treatment of severe haemophilia A in Limpopo, South Africa. Jean Paul Tshipeng Received Received
  PB-0654 Hospital-acquired venous thromboembolism among critically ill children undergoing invasive ventilation for acute respiratory failure is associated with impaired clot formation and fibrinolysis Steven Bruzek Received Received
  PB-0659 Filtration of heparin during preparation of a cardiopulmonary bypass circuit priming solution for infants. Paul Davies Received Received
  PB-0661 Platelet response following dexamethasone in obese vs. non-obese patients with primary, acute immune-mediated thrombocytopenia Jeffrey Gilreath Received Received
  PB-0662 CyTOF and microRNAs reveal possible biomarkers for early diagnosis and treatment of Heparin Induced Thrombocytopenia (HIT). Theodora Kostelidou Received Received
  PB-0669 Impact of the use of intravenous immunoglobulins and prednisone on newborns of mothers with platelet alloimmunization- a retrospective observational study Stephanie Lord Received Received
  PB-0694 Heavy menstrual bleeding is a common, underrecognized issue in at risk adolescents with immune thrombocytopenia and inherited platelet disorders. Michele Lambert Received Received
  PB-0700 Identifying Unmet Needs Related to Treatment and Disease Control in Immune Thrombocytopenia (ITP): US Patient Survey Shannon Campbell Received Received
  PB-0708 Heparin-induced thrombocytopenia among patients with end-stage renal disease in Gombe, Nigeria Saleh Yuguda Received Received
  PB-0719 Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis: a case report Naidan Zhang Received Received
  PB-0728 Role of the mechanotransductor PIEZO1 in megakaryocyte differentiation Christilla Bachelot-Loza Received Received
  PB-0741 Platelet Count Recovery as a Pragmatic Diagnostic Tool for Predicting Mortality after Cardiac Surgery Nathan Clendenen Received Received
  PB-0748 Identification of key regulators of procoagulant COAT platelet generation by quantitative temporal phosphoproteomic analysis Alessandro Aliotta Received Received
  PB-0759 MicroRNA-223-3p decreases platelet procoagulant activity through the regulation of TMEM16F Pierre Fontana Received Received
  PB-0771 Testosterone Replacement Therapy Does Not Alter Stored Platelet Hemostatic Capacity Kimberly Thomas Received Received
  PB-0781 Liposome-assisted uptake of procoagulant proteins by platelets Herm Jan Brinkman Received Received
  PB-0787 Role of ed microRNAs in regulation of hemostasis in zebrafish larvae Pierre Fontana Received Received
  PB-0808 The L33P polymorphism of integrin 3 PSI domain displays enhanced thiol isomerase activity and upregulates the coagulation cascade Heyu Ni Received Received
  PB-0830 Mechanisms of 4-Hydroxy-2-nonenal (HNE)-induced thromboinflammation Shabbir Ansari Received Received
  PB-0832 Targeting endothelial dysfunction when treating convalescent COVID-19 patients from a moderate or severe clinical presentation and the effect on serum biomarkers. A randomized placebo-controlled trial Alejandro gonzalez ochoa Received Received
  PB-0856 Antiplatelet Effects of Hydroxychloroquine in Patients with Systemic Lupus Erythematosus evaluated by Total Thrombus-formation Analysis System (T-TAS) Daisuke Hiraoka Received Received
  PB-0862 Targeting Neutrophil Extracellular Trap Formation under Flow in Patients with Immune Thrombotic Thrombocytopenic Purpura Noritaka Yada Received Received
  PB-0878 Physiologically Relevant NETosis Induction Reveals Distinct Triggers and Chromatin Changes Maisie Spurling Received Received
  PB-0880 Risk stratification utilizing Sequential Organ Failure Assessment (SOFA) score, antithrombin activity, and demographic data in sepsis-associated disseminated intravascular coagulation (DIC) Tomoki Tanigawa Received Received
  PB-0883 Platelet Function Testing in Sepsis Dermot Cox Received Received
  PB-0892 Risk of venous thromboembolism with short-term ozone air pollution among at-risk groups &8203; Scott Woller Received Received
  PB-0914 Prevalence of Thromboembolic disease associated with hospitalization in Hospital de Clinicas-Uruguay from January 2021 to December 2022 Maria Cecilia Guillermo Esposito Received Received
  PB-0923 Biomarkers for prediction of thrombus resolution after acute deep vein thrombosis in the lower extremities Damon Houghton Received Received
  PB-0930 Hypoxia and right ventricular strain in patients with acute pulmonary embolism Christopher Kabrhel MD MPH Received Received
  PB-0932 Safety and efficacy of low molecular weight heparin in patients with acute venous thromboembolism post-thrombolytic therapy as compared to unfractionated heparin: A systematic Review and Meta-analysis Eman Mansory Received Received
  PB-0938 Clinical Factors Associated with Low Antithrombin Activity Among Patients with Acute Pulmonary Embolism: The Thromboembolism Heparinization and AntithrombiN Observational Study (THANOS) Christiana Prucnal MD ScM Received Received
  PB-0945 Isolated deep vein thrombosis and isolated pulmonary embolism - are there any differences? Jana Hirmerova Received Received
  PB-946 The wide spectrum of pulmonary thromboembolism on electron microscopy and clinical implications Arthur Freedman, M.D. Received Received
  PB-0949 Whole PROC gene sequencing to explain genetically unresolved protein C deficiency. Yohann Jourdy Received Received
  PB-0950 An APS ACTION international Core laboratory performance assessment of Lupus Anticoagulant test by Taipan and Ecarin snake venom clotting times Hannah Cohen Received Received
  PB-0954 Co-occurrence of extremely rare ENG S484S and V504M variants in two independent women with unexplained venous thrombosis. David-Alexandre Trégouët Received Received
  PB-0964 Endothelial activation of protein C is disproportionately impaired in hereditary protein C deficiency Nadine Schwarz Received Received
  PB-0968 Evaluation of an automated Protein C antigen assay Thomas Pitchford Received Received
  PB-0970 Klippel-Trenaunay Syndrome: a rare disorder with complex hemostatic and thrombotic challenges Markie Zimmer Received Received
  PB-0972 Germline JAK2 V617F Variant in Patient with Unprovoked Cerebral Venous Sinus Thrombosis miguel escobar Received Received
  PB-0974 Exploring Acquired Thrombophilia: Insights from a 5-Year retrospective analysis of patients with venous thrombosis in a tertiary care centre in south India. Gohul Jalajakumari Received Received
  PB-0977 Bovine thrombin-associated antiphospholipid syndrome Markie Zimmer Received Received
  PB-0984 The Incidence of Major Bleeding and Case Fatality Rates in Patients Anticoagulated with Factor Xa Inhibitors: An Observational Study in the UK Clinical Setting (AXIOM UK) JB Mamza Received Received
  PB-0985 Evaluating a universal calibrator for anti-Xa testing in patients taking rivaroxaban and apixaban Emma Leitinger Received Received
  PB-0988 Assessing andexanet alfa Prescribing and Administration Practices: A Single Institution Study to Improve Patient Safety Marwan Shaikh Received Received
  PB-0990 Efficacy of a Platelet-derived Hemostatic Agent in Reversing P2Y12 Antagonist Therapy in Vivo Thomas Diacovo Received Received
  PB-0992 Impact of thrombocytopenia on bleeding and thrombotic complications in patients with atrial fibrillation starting anticoagulation: a time varying analysis. Kevin Barnum Received Received
  PB-0993 Anticoagulation stewardship: The new standard of care in anticoagulant safety. Experiences from a large, tertiary, multicentre health service. Emma Leitinger Received Received
  PB-1000 Estimates of 2024 Preventable Deaths in US Patients Treated with Apixaban and Rivaroxaban Requiring Reversal for Major Bleeding Events Charles Mahan Received Received
  PB-1001 Anticoagulation for Venous Thromboembolism (VTE) in patients aged 80 years: a focus on bleeding Jignesh Patel Received Received
  PB-1004 D-dimer monitoring to guide anticoagulation management in patients receiving venoarterial-extracorporeal membrane oxygenation: a retrospective cohort study Litao Zhang Received Received
  PB-1009 Assessment and Management of Toxic Coagulopathies at the Yeolyan Hematology and Oncology center: A 7-Year Retrospective Analysis (2016-2022) Heghine Khachatryan Received Received
  PB-1015 Application of Thromboelastography in Pediatric Liver Transplantation: Insights from Mexican Patients. Instituto Nacional de Pediatria, Mexico City, Mexico MARA NUNEZ TOSCANO Received Received
  PB-1016 Incidence and risk factors for early bleeding complications in patients with acute myeloid leukemia Radhika Gangaraju Received Received
  PB-1020 Acquired Haemophilia Spanish registry, characteristics of infectious complications after 10 years activity Maria Eva Mingot-Castellano Received Received
  PB-1023 Development of Sepsis induced Coagulopathy is associated with death in late onset sepsis in Neonates Daniel OReilly Received Received
  PB-1024 Disseminated intravascular coagulation predicts a poor prognosis for out-of-hospital cardiac arrest patients receiving veno-arterial extracorporeal membrane oxygenation Satoshi Gando Received Received
  PB-1038 Hemostasis disorders induced by Bothrops atrox and Bothrops lanceolatus venoms: in vivo study Georges Jourdi Received Received
  PB-1049 ROTEM Thromboelastometry System- Caution in interpretation Vishnu Prasad Received Received
  PB-1052 Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies Yi-Feng Wu Received Received
  PB-1053 Therapeutic Window of a Synthetic Platelet Nanotechnology in New Zealand White Rabbits Anirban Sen Gupta Received Received
  PB-1056 Assessment of the haemostatic potential of platelets readied for transfusion Dermot Cox Received Received
  PB-1065 Risk factors associated with blood transfusion in liver transplantation Antoni Sabate Received Received
  PB-1066 Fibrinogen repletion for perioperative bleeding management: clinical use of cryoprecipitate, fibrinogen concentrate, and target levels used in clinical practice in the United States Sarah Baker Received Received
  PB-1068 Management of patients requiring oral anticoagulant reversal for surgical emergencies or major bleeding: clinical practice in the United States Sarah Baker Received Received
  PB-1069 Perioperative Management of Major Bleeding: A Survey of Treatment Practices from Members of the American Society of Anesthesiology Sarah Baker Received Received
  PB-1076 Reduction of plasma kallikrein by in vivo CRISPR-based gene editing of KLKB1 does not alter coagulation in patients with hereditary angioedema Stephanie Proulx Received Received
  PB-1079 Elevated plasma factor XI is associated with postthrombotic syndrome Anna Hojda Received Received
  PB-1082 Intratumoral administration of anticoagulant Protein S reduces tumor volume in nude mouse model of pancreatic cancer. Rinku Majumder Received Received
  PB-1087 Beyond bleeding: Exploring coagulation factors and cytokines in bone health in vitro Aline Bernar Received Received
  PB-1097 Salvianolic Acid B Inhibits Thrombosis and Directly Blocks the Thrombin Catalytic Site Heyu Ni Received Received
  PB-1100 Disulfide-bonded Forms of Prothrombin are Differentially Targeted by Anti-Prothrombin Antiphospholipid Antibodies Mark Schreuder Received Received
  PB-1104 Understanding distinct conformational states of full-length coagulation Factor VIII and its complex with vWF : A comprehensive AFM analysis Samhitha Urs Ramaraje Urs Received Received
  PB-1107 Specific Mutations in Blood Coagulation Factor VIII Have a Cumulative Effect for Increasing its Secretion Andrey Sarafanov Received Received
  PB-1112 THE PROCOAGULANT SIGNATURE OF CANCER CELLS DRIVES FIBRIN CLOT SHIELDS FORMATION IN TUMOR MICROENVIRONMENT AND IMPACTS ITS QUALITY. IMPLICATIONS IN CANCER CELL MIGRATION Patrick Van Dreden Received Received
  PB-1119 The impact of recombinant factor ? products on inhibitor development in previously untreated and previously treated children with hemophilia A: a systematic review Jing Sun Received Received
  PB-1121 Human missense variants in F3 impair the initiation of blood coagulation Shabbir Ansari Received Received
  PB-1128 Serial thromboelastography as bleeding and mortality predictors in severe COVID-19 patients Usi Sukorini Received Received
  PB-1132 Enhancing adverse drug event surveillance through natural language processing: Focus on hemorragic events identification from clinical narratives Frédéric Gaspar Received Received
  PB-1133 Validating the JAKPOT prediction rule for identifying which patients with erythrocytosis are unlikely to have a JAK2 mutation Barbara Lam Received Received
  PB-1134 A Swiss National Initiative to develop and validate a multi-modal, multi-source, multi-centric data-driven approach for antithrombotic adverse drug events detection in older inpatients Claire Coumau Received Received
  PB-1150 Shear rates in hemorrhagic vascular injury Gian Rivera Crespo Received Received
  PB-1161 Investigation of coagulation characteristics in animal blood used for development of cardiovascular devices Osamu Kumano Received Received
  PB-1164 A clinical study on establishment and evaluation of autoverification rules for coagulation tests Lei Zhang Received Received
  PB-1165 APAC, a heparin proteoglycan mimic, is a potent von Willebrand Factor-mediated antithrombotic over collagen in a microfluidic blood perfusion system under high shear rate Annukka Jouppila Received Received
  PB-1169 New 3D-printable, Hemo- and Biocompatible Non-Isocyanate Polyurethane Elastomers for the Manufacturing of Blood-contacting Medical Devices Sofia Melo Received Received
  PB-1171 Design, Manufacturing and Testing of a Green Non-Isocyanate Polyurethane Prosthetic Heart Valve Sofia Melo Received Received
  PB-1186 Myeloproliferative neoplasms with thrombocytosis and acquired von Willebrand disease: a single centre experience. Susie Shapiro Received Received
  PB-1190 Factor VIII inhibitors exhibit either type I or type II kinetics in acquired haemophilia A Paul Batty Received Received
  PB-1207 Prevalence of vitamin D deficiency in patients with haemophilia in a Comprehensive Treatment Center in Mexico City. Maria-Teresa Garcia-Lee Received Received
  PB-1210 Exploring the Mental Health and Resilience of Youth Diagnosed with Hemophilia: A Scoping Review Ante Cuvalo Received Received
  PB-1215 Sequential combined bypassing therapy in congenital haemophilia patients with inhibitors to VIII or IX factors: Surgical experience Hu Zhou Received Received
  PB-1220 Cardiovascular Risk Factors in a Large Multi-Institutional Cohort of Persons with Hemophilia Brandon M Hardesty Received Received
  PB-1222 Cut-off score for identifying patients at risk of Hemophilia using a Hemophilia self-screening tool in resource-constrained settings Wulandewi Marhaeni Received Received
  PB-1223 A study of the mood state for mothers of children with hemophilia Aya Nakao Received Received
  PB-1225 Orthopedic assessment in patients with hemophilia and Von Willebrand disease in a mexican population Yoriko Fabiola Rojas Sato Received Received
  PB-1227 Using the Hemophilia Functional Ability Scoring Tool (Hemo-FAST) to describe the joint health status in adults with hemophilia Liz Beatty Received Received
  PB-1230 APTT sensitivity to mild Haemophilia B, data from 900 participants registered with the UK NEQAS BC programme in 2023. christopher reilly-stitt Received Received
  PB-1241 Successfully retinoblastoma surgery in a Severe Hemophilia A with an incomplete impregnation dose of Emicizumab, Instituto Nacional de Pediatria, Mexico city, Mexico MARA NUNEZ TOSCANO Received Received
  PB-1260 First report of a Mexican family with F8 c.1443GA mutation causing mild hemophilia Maria-Teresa Garcia-Lee Received Received
  PB-1264 The Association between Unemployment and Treatment Among Adults with Hemophilia Christian Qvigstad Received Received
  PB-1278 Thrombocytopenia in cardiovascular disease, surgery, and its implicationsInstituto Nacional de Pediatria, Mexico city , Mexico MARA NUNEZ TOSCANO Received Received
  PB-1283 Determinants of genotype-phenotype correlations of MYH9 variants: lessons from patients with codon 1424 mutations. Leah Bhandal Received Received
  PB-1292 Characterization of three patients with moderate bleeding diathesis and platelet dysfunction associated with novel genetic variants in GP6 and P2RY12 José Rivera Pozo Received Received
  PB-1293 Genetic Landscape of Inherited Thrombocytopenia: Eight Years of Experiences in a Large Polish Cohort Bartosz Urbanski Received Received
  PB-1295 Dose Genotype Correlate with Phenotype Among Glanzmann Thrombasthenia Patients? Ahmad Tarawah Received Received
  PB-1298 Heavy menstrual bleeding is a common indication for evaluation for platelet disorders in adolescents. Michele Lambert Received Received
  PB-1300 A Rare Familial GP1BA Variant Causing Autosomal Dominant Bernard-Soulier Syndrome Sonata Saulyte Trakymiene Received Received
  PB-1303 Identification of a novel mutation in the NBEAL2 gene in a patient with gray platelet syndrome Tatsuya Konishi Received Received
  PB-1307 Molecular profiling of a patient with combined thrombocytopenia and connective tissue disorder Nina Borràs Agustí Received Received
  PB-1310 May-Hegglin Anomaly: are giant platelets a giant problem? Markie Zimmer Received Received
  PB-1327 Searching for a reliably predictive PLASMIC score: Results of a multicenter study Mouhamed Yazan Abou-Ismail Received Received
  PB-1328 The therapeutic efficacy of daratumumab in the management of multiply relapsed refractory immune thrombotic thrombocytopenic purpura: an Australian single centre experience. Pratheepan Puvanakumar Received Received
  PB-1342 Anti-angiogenic activity of novel plasminogen fragments produced by a bacterial metalloproteinase ERIKO SUZUKI Received Received
  PB-1348 Impact of Neutrophil extracellular traps (NETs) on endothelial cell behavior and procoagulant proteins up-regulation Massoud Mirshahi Received Received
  PB-1354 Effect of tinzaparin, apixaban, enoxaparin and quercetin and on the expression of procoagulant properties of cancer cells and endothelial cells exposed to cancer cell derived microvesicles patrick Van Dreden Received Received
  PB-1355 Aortic endothelial cells response to pulsatile vs continuous flow at high shear stress Christina Le Tanno Received Received
  PB-1372 Trajectory of immunothrombosis biomarkers in a fecal-induced peritonitis (FIP) model of murine sepsis Dhruva Dwivedi Received Received
  PB-1375 Impact of ticagrelor pretreatment in a cecal slurry mouse model of polymicrobial abdominal sepsis Alexandre Mansour Received Received
  PB-1403 Impact of determining clinical risk factors and biomarkers on the risk of cancer-associated thrombosis in newly diagnosed patients with multiple myeloma. The observational Roadmap-CAT-MM patrick Van Dreden Received Received
  PB-1404 Management and outcomes in patients with tumor thrombus: A retrospective cohort study Tzu-Fei Wang Received Received
  PB-1411 Altered whole blood thrombin generation and hyperresponsive platelets associate with thromboembolic events in patients with pancreatic ductal adenocarcinoma Ruth Willems Received Received
  PB-1432 Tissue Factor mRNA (TF mRNA) and Activated FVII-Antithrombin Complex (FVIIa/AT) As Potential Markers of Thrombo-Hemorrhagic Events (THE) in APL Patients Anna Falanga Received Received
  PB-1444 Survival effects of intraoperative thromboprophylaxis with low-molecular-weight heparin or heparin in patients undergoing colorectal cancer resection: A post-hoc analysis of PERIOP-01 trial Tzu-Fei Wang Received Received
  PB-1446 Direct oral anticoagulants for thromboprophylaxis in multiple myeloma a systematic review and meta-analysis Catalina Codreanu Received Received
  PB-1451 Development of Occult Myeloproliferative Neoplasm in Patients with Venous Thromboembolism and JAK2 Positive Mutation: A Systematic Review Nathalie Loeb Received Received
  PB-1454 Outpatient antithrombotic prophylaxis during chemotherapy treatment. Experience in clinical practice at Lucus Augusti University Hospital (Lugo, Spain). Alvaro Lorenzo Vizcaya Received Received
  PB-1464 Experience with direct oral anticoagulants in hematological malignancies at the Hematology Service of the Clínicas University Hospital. Montevideo-Uruguay Maria Cecilia Guillermo Esposito Received Received
  PB-1466 Safety and efficacy of DOACs in cirrhotic and non-cirrhotic splanchnic vein thrombosis: preliminary results from a prospective observational study. Rosa Talerico Received Received
  PB-1471 A Multidisciplinary Splanchnic Vein Thrombosis Clinic: Experiences from the First Year Rushad Patell Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
18:10
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

ISTH 2024 Congress

 

June, 22-26 Bangkok
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 22/06/2024 TO 22/06/2024
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert